SCHEMBL24510084

SCHEMBL24510084

N#Cc1cccc(-c2c(-n3c4ccccc4c4ccccc43)c(-n3c4ccccc4c4ccccc43)c(-n3c4ccccc4c4ccc5c(c6ccccc6n5-c5ccccc5)c43)c(-n3c4ccccc4c4ccccc43)c2-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.39
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ ADORA2A P29274 2/20 0.35
▸ GABRA1 P14867 1/20 0.34
▸ GABRG2 P18507 1/20 0.34
▸ GABRB3 P28472 1/20 0.34
▸ GABRA5 P31644 1/20 0.34
▸ GABRA3 P34903 1/20 0.34
▸ CYP1A2 P05177 6/20 0.33
▸ KMT2A Q03164 5/20 0.33
▸ CYP3A4 P08684 5/20 0.33
▸ ALDH1A1 P00352 5/20 0.33
▸ MEN1 O00255 4/20 0.33
▸ LMNA P02545 4/20 0.33
▸ TSHR P16473 4/20 0.33
▸ CYP2D6 P10635 4/20 0.33
▸ CLK4 Q9HAZ1 4/20 0.33
▸ HSD17B10 Q99714 4/20 0.33
▸ CYP2C19 P33261 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24510081 0.97 KDM4E (0.37) KDM4EATML3MBTL1ADORA2AGABRA1
SCHEMBL21546635 0.91 KDM4E (0.39) KDM4EATML3MBTL1ADORA2AGABRA1
SCHEMBL24510039 0.90 KDM4E (0.39) KDM4EATML3MBTL1KMT2APGR
SCHEMBL24510015 0.89 ATM (0.41) KDM4EATML3MBTL1CYP1A2KMT2A
SCHEMBL22457798 0.89 KDM4E (0.40) KDM4EATML3MBTL1ADORA2AGABRA1
SCHEMBL21188690 0.87 KDM4E (0.39) KDM4EATML3MBTL1ADORA2AGABRA1
SCHEMBL22457790 0.87 KDM4E (0.38) KDM4EATML3MBTL1ADORA2AGABRA1
SCHEMBL24510083 0.86 KDM4E (0.43) KDM4EATML3MBTL1ADORA2AGABRA1
SCHEMBL24510082 0.86 KDM4E (0.43) KDM4EATML3MBTL1ADORA2AGABRA1
SCHEMBL21929246 0.86 GABRA1 (0.37) KDM4EATML3MBTL1ADORA2AGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185824-A1 PI-CONJUGATED COMPOUND, METHOD FOR PRODUCING PI-CONJUGATED COMPOUND, INK COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, LIGHT EMITTING MATERIAL, CHARGE TRANSPORT MATERIAL, LIGHT EMITTING FILM AND ORGANIC ELECTROLUMINESCENT ELEMENT Konica Minolta, Inc. (JP) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185824-A1 PI-CONJUGATED COMPOUND, METHOD FOR PRODUCING PI-CONJUGATED COMPOUND, INK COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, LIGHT EMITTING MATERIAL, CHARGE TRANSPORT MATERIAL, LIGHT EMITTING FILM AND ORGANIC ELECTROLUMINESCENT ELEMENT NAP1L1, XPO6, INTS6 KDM4E 3483/4885ATM 2901/4885L3MBTL1 1836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback